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Epidemiological studies have clearly demonstrated a strong association between low birth weight and long-term renal disease. A
potential mediator of this long-term risk is a reduction in nephron endowment in the low birth weight infant at the beginning
of life. Importantly, nephrons are only formed early in life; during normal gestation, nephrogenesis is complete by about 32–36
weeks, with no new nephrons formed after this time during the lifetime of the individual. Hence, given that a loss of a critical
number of nephrons is the hallmark of renal disease, an increased severity and acceleration of renal disease is likely when the
number of nephrons is already reduced prior to disease onset. Low birth weight can result from intrauterine growth restriction
(IUGR) or preterm birth; a high proportion of babies born prematurely also exhibit IUGR. In this paper, we describe how IUGR
and preterm birth adversely impact on nephrogenesis and how a subsequent reduced nephron endowment at the beginning of life
may lead to long-term risk of renal disease, but not necessarily hypertension.
1. Introduction
Low birth weight infants are at increased risk of renal disease.
A reduced complement of nephrons at the beginning of life
in infants that are intrauterine growth restricted (IUGR)
and/or born preterm may be the cause of their long-term
risk of renal disease. A reduced nephron endowment in
low birth weight infants may also lead to vulnerability to
hypertension in adulthood; however, experimental evidence
suggests that they are not causally linked. In this paper we
discuss how IUGR and preterm birth adversely impact on
nephron endowment and how this has the potential to lead
to deleterious effects on renal health.
The novelty of this paper is the emphasis on both preterm
birth and IUGR leading to low birth weight; the effects
of preterm birth on the kidney have only recently been
described, and many of these studies have been undertaken
in our laboratory. In this regard, much of the information
reported in this paper has been derived from studies over the
last decade in our laboratory.
2. Low BirthWeight due to IUGR and/or
Preterm Birth
Low birth weight is defined as a birth weight of an infant less
than 2500 grams at full term [1]. It can result from intrauter-
ine growth restriction and/or preterm birth. IUGR is often a
comorbidity of preterm birth and it is linked with induction
of assisted and nonassisted premature delivery [2, 3].
2.1. Intrauterine Growth Restriction (IUGR). The diagnosis
of IUGR is assigned to infants with a birth weight and/or
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Figure 1: Intrauterine growth restriction (IUGR) can result from a variety of maternal, placental, and fetal factors, either individually or in
combination.
birth length below the 10th percentile for gestational age
[4]. IUGR is multifactorial in origin and occurs in 4–10%
of all term pregnancies [5]; as shown in Figure 1, IUGR is a
manifestation of many possible fetal, placental, and maternal
disorders [1]. Restriction of blood flow to the fetus is a
common element to most IUGR pregnancies, resulting in
lack of oxygen and nutrient delivery to the fetus [6, 7]. In
developing countries, the major cause of IUGR is maternal
undernutrition and/or malnutrition, whereas in developed
countries, the majority of IUGR pregnancies are the result of
placental insufficiency. The placenta is an important interface
betweenmother and fetus, supplying oxygen and nutrients to
the fetus and removing waste products. Hence, the maternal
and fetal components of the placenta must be adequately
perfused [8]. Placental insufficiency is mainly due to an inad-
equate vascular adaptation at the uteroplacental interface [9],
which ultimately leads to fetal hypoxia and hypoglycaemia
and subsequent fetal growth restriction [9, 10].
2.2. Preterm Birth. Preterm birth is defined as birth prior to
37 completed weeks of gestation [11]; it can be further sub-
divided according to severity [12]: near term (34–37 weeks
gestation), moderately preterm (32-33 weeks gestation), very
preterm (28–31 weeks gestation), and extremely preterm
(<28 weeks gestation). Preterm birth currently accounts for
9.6% of births worldwide [13], with 12.3% of births in the
USA [14] and 8.2% of births in Australia [15] being preterm.
In developing countries, the incidence of preterm birth is
generally higher; for example, the rates of preterm birth in
southern Africa are 17.5% [13].
The proportion of preterm births is different for each
gestational age category, with the majority of preterm births
being near term; approximately 60% of preterm births
are at 34–36 weeks gestation, 20% at 32-33 weeks, 15% at
28–31 weeks, and just 5% of preterm births are at less than
28 weeks gestation [12]. The incidence of preterm birth
continues to rise worldwide [16–18]; this is largely attributed
to the escalating use of assisted reproductive therapies over
recent years (which has increased the number of multiple
births) and to the rise in the number of deliveries following
clinical intervention [12, 19]. More accurate assessments of
gestational age at birth in recent times are also likely to have
contributed to the number of neonates classified as being
preterm [18].
The majority of preterm births (approximately 40%)
occur due to spontaneous preterm labour, 25% occur
following premature prelabour rupture of membranes, and
35% are clinically indicated [12]. The cause of preterm birth
is often multifactorial in origin, with a large number of risk
factors identified. These include maternal ethnicity, previous
preterm birth, short time interval between pregnancies,
low maternal body mass index, maternal smoking, multiple
pregnancy, maternal stress, and also maternal medical con-
ditions such as depression, cervical incompetence, thyroid
disease, asthma, diabetes, and hypertension. The most sig-
nificant contributor to preterm birth is intrauterine infection
(including chorioamnionitis), which may be involved in up
to 40% of preterm births [20, 21].
Importantly, both IUGR and preterm birth have the
potential to adversely impact on kidney development; in
the case of IUGR, this occurs in utero and in preterm
infants, this occurs in the early neonatal period (Figure 2).
This is particularly important in relation to the timing of
nephrogenesis (the formation of nephrons) in the kidney.
3. Renal Development
The formation of the metanephric kidney commences at
approximately week 5 of gestation with an outgrowth of cells
from the caudal end of the nephric duct termed the ureteric
bud [22, 23]. Reciprocal interactions subsequently occur
between the ureteric bud and the metanephric mesenchyme,
a mass of embryonic cells located at the base of the nephric
cord. These interactions result in the differentiation of the
mesenchyme to form nephrons and the growth and bifurca-
tion of the ureteric bud to form the collecting ducts [22, 24].
The architecture of nephron arrangement within the
human kidney is derived through the process of branching
morphogenesis. As described by Osathanondh and Potter
[23], 6–8 generations of ureteric branches form distal to the
minor calyces by the completion of ureteric bud branching
at approximately week 14-15 of gestation, with nephrons
induced to differentiate at the ureteric bud tips (ampullae)
from approximately the 9th week of gestation. After the
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Figure 2: Flow diagram showing the consequences of intrauterine
growth restriction (IUGR) and preterm birth which result in low
birth weight. Low birth weight may have an adverse effect on
nephron endowment and glomerular hypertrophy; together, these
may increase the vulnerability of an individual born IUGR or
preterm to long-term renal disease.
cessation of active branching, 2–8 additional nephrons are
induced to form at branch tips that have previously generated
a nephron; in this way, generations of nephrons are formed
in an arcade arrangement. The final nephrons formed after
approximately 22 weeks gestation are attached individually to
the terminal end of the ureteric branches; 8–10 generations
of nephrons are formed in the human kidney by the
completion of nephrogenesis [23, 25].
In the process of nephrogenesis, the induced mes-
enchyme condenses at the tip of the ureteric bud to form
aggregates which then mature into renal vesicles. These
subsequently progress into “comma shaped” and “S-shaped”
bodies. The S-shaped body then fuses with a collecting
duct and differentiates into a nephron. The renal corpuscle
(comprised of the glomerulus and the Bowman’s capsule)
arises from the lower limb of the S-shaped body through
a process of glomerulogenesis. Firstly, the inner cells of
the lower cleft of the S-shaped body differentiate into the
glomerular (visceral) podocytes, while the outer cells form
the parietal podocytes which line the Bowman’s capsule [22,
23, 26]. During the differentiation of podocytes, endothelial
precursor cells from the mesenchyme invade the lower cleft
and differentiate to form the capillary loop [27]. Both the
podocyte epithelium and the developing endothelial cells
actively synthesise the components required to form the
shared glomerular basement membrane. The podocytes fuse
with the developing glomerular basement membrane and
further differentiate to form foot processes; the endothelium
flattens and becomes fenestrated [27].
4. IUGR and Preterm Birth Adversely Impact
on Nephrogenesis
Importantly, nephrogenesis is normally completed by 32–
36 weeks gestation, with no new nephrons formed for
the lifetime of the individual after this time [23, 28]. The
nephrons are the functional units of the kidney, hence, the
number of nephrons formed within the kidney at completion
of nephrogenesis directly influences lifetime renal functional
capacity and reserve [29]; it is essential, therefore, that
adequate nephrogenesis is achieved at the very beginning
of life. Autopsy studies over the past two decades have
demonstrated that there is a wide range in nephron number
in the human kidney [30–38]; overall, nephron number
has been shown to range from approximately 200,000 to
over 2 million per kidney [39]. The wide range in nephron
number between individuals is likely attributed to differences
in nephron endowment by the completion of nephrogenesis
(which may be due to genetic and/or environmental factors),
as well as differences in the exposure to secondary insults
throughout life, which lead to loss of nephrons. In this
regard, exposure to IUGR and/or preterm birth can nega-
tively impact on nephrogenesis and thus adversely impact on
nephron endowment at the beginning of life.
5. IUGR Leads to a Reduction in
Nephron Endowment
A number of autopsy studies have reported a significant
reduction in nephron number as a result of IUGR [31,
40, 41]. For example, it was found that nephron number
in stillborn infants with IUGR was significantly reduced
compared to infants that were appropriately grown-for-
gestational age [40]. In another study, a linear relation-
ship was reported between the number of glomeruli (and
therefore nephrons) and birth weight in full-term neonates;
neonates below the 10th percentile of birth weight had 30%
fewer glomeruli than the neonates with birth weights above
the 10th percentile [41]. In addition, many experimental
studies in various animal models demonstrate that IUGR
leads to a reduced nephron endowment at birth. Indeed,
a low nephron endowment has been reported following
naturally occurring IUGR due to twinning [42–44] and
in experimentally induced IUGR offspring as a result of
maternal nutritional deprivation [45, 46], maternal protein
restriction [47–51], uterine artery ligation [52], and placental
embolisation [10, 53]. In general, at the time of birth, kidney
size is proportional to body size and nephron number is
directly proportional to kidney size [54–56]; however, in the
event that the growth restriction occurs late in gestation
when nephrogenesis is complete (or nearing completion),
this relationship does not exist [53].
6. Nephrogenesis Continues after
Preterm Birth, but There Is Evidence of
Glomerular Abnormalities and Acceleration
of Renal Maturation
It has been proposed in previous studies that preterm birth
leads to a reduced nephron endowment; Rodrı´guez et al.
[57] found that preterm neonates (in particular those with
a history of acute renal failure) had a significantly reduced
number of glomerular generations compared to term-born
controls. Additionally, a recently published experimental
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Figure 3: A representative photomicrograph of a histological
renal section showing morphologically abnormal glomeruli (with
enlarged Bowman’s spaces and shrunken glomerular tufts) in the
outer renal cortex of a preterm baboon kidney (indicated by
arrows).
study demonstrated that a 20% reduction in nephron
number occurred following premature delivery at 1-2 days
prior to term birth in a preterm mouse model [58].
Preterm birth occurs at a time when nephrogenesis is
often ongoing in the kidney of the infant. In our laboratory,
we have clearly demonstrated in both baboon and human
kidneys that nephrogenesis continues after preterm birth
[54, 59]; observation of kidney sections from these preterm
neonates clearly demonstrates an active nephrogenic zone
with evidence of developing immature glomeruli. Further-
more, using unbiased stereological techniques, we have
shown that the number of glomerular generations and the
total number of nephrons increases in the postnatal period
after preterm birth, thus, indicating that nephrogenesis
continues in the extrauterine environment [54, 59]. Total
nephron number appears to be within the normal range,
albeit at the lower end of the normal range [54].
Of particular concern, many of the glomeruli in the
outer cortex appeared markedly abnormal in some of the
preterm kidneys; the number of abnormal glomeruli varied
widely, from less than 1% to as high as 13% of glomeruli
in the preterm human kidney [59] and 22% in the preterm
baboon kidney [54, 55, 60]. As shown in Figure 3, the
abnormal glomeruli exhibit a cystic morphology with a
grossly enlarged Bowman’s space. They are located within the
outer renal cortex and are observed to be in an immature
stage of development; the glomerular tuft is composed of
an undifferentiated anlage of cells surrounded by a layer of
podocytes with scant, if any, capillarisation [54, 55].
Our findings thus strongly suggest that it is the glomeruli
formed postnatally in the extrauterine environment that
are vulnerable to abnormalities. The abnormal glomerular
morphology is characteristic of atubular glomeruli [61,
62], and if this is the case these glomeruli will never
be functional. Hence, in infants with a high proportion
of abnormal glomeruli, this will markedly impact on the
number of functional nephrons at the beginning of life.
Why some kidneys exhibit gross glomerular abnormalities
whereas others are relatively unaffected is unknown, but
likely relates to differences in the early postnatal care of
the preterm infants whilst in the neonatal intensive care
unit. For example, extremely preterm infants are known
to experience extrauterine growth restriction (EUGR) since
they generally do not achieve the normal rate of growth ex
utero as that in utero [63, 64]. This is likely to have significant
implications for ongoing nephrogenesis and consequently on
renal function in adult life, therefore, in future studies, it is
important to ascertain ways in which to achieve optimal renal
development in the neonatal intensive care unit setting.
7. Glomerular Hypertrophy and Accelerated
Renal Maturation in PretermNeonates
Interestingly, we have shown a marked increase in the size
of the preterm kidneys in the neonatal period which is not
proportional to body size [54, 59]. In this regard, although
absolute nephron number among preterm baboons was
found to be within the normal range, on average the number
of nephrons per gram of kidney tissue was significantly
reduced in preterm baboon kidneys; 83,840 nephrons/gram
were compared to 193,400 nephrons/gram in age-matched
gestational controls [54]. These findings thus imply that
there is glomerular hypertrophy (now clearly linked with
renal pathology) and increased tubular mass within the renal
cortex of the preterm kidneys. Quantitative examination
of kidney tissue from preterm human neonates that was
collected at autopsy subsequently confirmed that there was
both glomerular hypertrophy and accelerated maturation of
renal development in preterm kidneys after birth [59]. For
example, there was a significant reduction in the width of
the nephrogenic zone when compared to the kidneys from
appropriately grown postconceptional age-matched stillborn
infants [59]. Hence, although nephrogenesis was ongoing in
the preterm kidneys, the reduced width of the nephrogenic
zone implies that there was a diminished capacity to form
new nephrons, probably due to acceleration in renal matu-
ration. In support of this idea, we also showed a significant
reduction in the proportion of the most immature glomeruli
(vesicles) within the nephrogenic zone, indicative of fewer
new glomeruli forming in the extrauterine environment.
In addition to accelerated maturation, there was also
evidence of glomerular hypertrophy, probably due to the
increased functional demands on the kidney after birth
and/or an increase in renal blood flow. If this hypertrophy
persists into later life, it is likely to lead to deleterious
effects on renal function given that glomerular hypertrophy
is linked to renal pathology in adulthood [39, 65]. Indeed,
long-term hyperfiltration of hypertrophied glomeruli is
proposed to lead to the development of glomerulosclerosis
and subsequent glomerular loss [66, 67], thus, further
reducing the functional capacity of the kidney.
8. Renal Blood Flow Increases at Birth
The glomerular hypertrophy and accelerated renal mat-
uration in preterm infants are not surprising, given the
marked change in hemodynamics at the time of birth and
the increased functional demands on the kidney ex utero.
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Overall, the haemodynamic adaptations of the fetal kidney to
extrauterine life involve transformation from a high vascular
resistance fetal organ with low blood flow (primary blood
flow to the inner cortex), into a high blood flow, low vascular
resistance organ with primary blood supply to the outer renal
cortex [68]. Blood flow to the kidneys is very low during
fetal life, with a fetus at 10–20 weeks gestation only receiving
5% of cardiac output [69–71]. After birth, renal blood flow
almost doubles, increasing to approximately 9% of cardiac
output [69].
Importantly, studies in animal models with ongoing
postnatal nephrogenesis have shown that after birth there
initially remains a low blood flow to the outer renal cortex
which is likely a protective mechanism to protect developing,
immature glomeruli in this region of the kidney [72]. It is
unknown, however, whether this protective pattern of blood
distribution is also present in the kidney of the preterm
human neonate, which is especially important given that
these kidneys are structurally very immature and nephroge-
nesis is still ongoing in the outer renal cortex after birth.
9. Low BirthWeight Is Linked to
Long-Term Vulnerability to
Hypertension and Renal Disease
There are a number of studies both in humans and experi-
mental models showing a link between low birth weight and
long-term increases in blood pressure and susceptibility to
the development of renal disease.
A systematic review of eighty studies, that had inves-
tigated the relationship between levels of blood pressure
and birth weight, showed that in the majority of studies
(conducted in either children, adolescents, or adults) blood
pressure fell with increasing birth weight; there was an
approximately 2mmHg decrease in blood pressure for each
increase in 1 kg of birth weight [73]. Although these effects
on blood pressure appear relatively modest, they certainly
have the potential to magnify cardiovascular risk, especially
when other adverse life-style factors come into play. Indeed,
only small changes in blood pressure can elevate cardiovas-
cular risk; a relative rise of 2mmHg in blood pressure is
associated with 6% increased risk of coronary artery disease
and a 15% increased risk of stroke [74].
In addition to long-term effects on blood pressure, there
is substantial epidemiological data linking low birth weight
with chronic kidney disease. In this regard, a recent meta-
analysis of 31 relevant studies, conducted by White et al.
[75], concluded that subjects born of low birth weight have
a 70% greater risk of developing kidney disease. However,
the authors did emphasise the need for additional well-
designed population-based studies where confounders such
as maternal health and socioeconomic factors are taken into
account.
Most of the studies used in the meta-analyses described
above have not separated low birth weight due to IUGR
and preterm birth. Importantly, in this regard, there is now
mounting epidemiological evidence linking preterm birth
with the induction of hypertension in adults [76–84] and
even in children [85–87]; there is an inverse relationship
between gestational age at birth and level of blood pressure.
For example, a recent study reported a 0.53mmHg reduction
in systolic blood pressure for every 1 week increase in
gestational age at birth [83]. In addition, there are an
emerging number of reports of adverse effects on renal
function later in life in subjects that were born preterm
(Table 1). However, it is to be noted that renal impairments
are not a universal finding among studies involving preterm
neonates which may be related to the more severe outcomes
found among extremely preterm neonates born with a
very low birth weight (VLBW; defined as birth weight less
than 1000 grams). In support of this idea, Keijzer-Veen
et al. [88] reported lower glomerular filtration rate and
higher urinary albumin excretion in adults born extremely
preterm who were also small-for-gestational age, compared
to those born preterm and appropriate-for gestational age.
Among children, Kwinta et al. [89] reported impaired renal
function and reduced kidney volume among VLBW preterm
neonates at 6-7 years of age and Zaffanello et al. [90] showed
increased protein excretion among children born extremely
LBW compared to children born VLBW. As discussed earlier,
postnatal nutrition and weight gain may adversely impact
on ongoing nephrogenesis and long-term renal function;
in relation to this, Bacchetta et al. [91] have demonstrated
lower glomerular filtration rate (albeit in the normal range)
among children born very preterm (<30 weeks gestation)
that were either IUGR or EUGR, compared to children with
appropriate prenatal and postnatal growth. Furthermore,
Kwinta et al. [89] have demonstrated a 33% reduced odds
of renal impairment among children born very low birth
weight if they gained weight during their stay at the neonatal
intensive care unit.
The mechanisms leading to the increased risk of devel-
oping elevated blood pressure and vulnerability to long-
term renal disease in low birth weight infants are currently
unknown; a reduced nephron endowment at the beginning
of life are postulated to play a role.
10. A Reduced Nephron Endowment in
Early Life Is Not Causally Linked to
the Development of Hypertension, but
Likely Leads to Vulnerability to
Long-Term Renal Disease
Convincing evidence from renal cross-transplantation stud-
ies directly implicates the kidney in the induction of essen-
tial/primary hypertension. For example, both human and
experimental studies have shown that when the kidney from
a hypertensive donor is transplanted into a normotensive
recipient, it leads to the induction of hypertension in the
recipient; the opposite occurs when the kidney from a
normotensive donor is transplanted into a hypertensive
recipient [97–100]. Further supporting the role of the kidney
in the aetiology of hypertension, when a kidney from a young
spontaneously hypertensive rat (prior to the onset of high
blood pressure) is transplanted into a normotensive breed of
rat, the recipient develops hypertension in early adulthood
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as is normally seen in the spontaneously hypertensive donor
[97].
In the late 1980s, Brenner et al. [101] put forward the
hypothesis that the fundamental renal abnormality that leads
to hypertension is a reduced filtration surface area; this could
be brought about by a reduction in the number of nephrons
in the kidney and/or a decrease in renal filtration surface area
per nephron [101]. Since, Brenner and colleagues initially
put forward this hypothesis, there have been a multitude
of experimental studies investigating the effects of early
life insults (such as IUGR) on nephron endowment at the
beginning of life [48, 53, 56, 102] and the long-term effects
on blood pressure [48–50, 52, 103–107]. Although there
has been considerable experimental support for the concept
that a reduced nephron endowment leads to hypertension,
the findings are far from universal. For instance, in the rat
model of maternal protein restriction Langley-Evans et al.
[48], Sahajpal and Ashton [104], Woods et al. [108, 109]
have observed long-term elevations in blood pressure in the
presence of a reduced nephron endowment, whereas studies
from our and other laboratories show no rise in blood
pressure in adulthood [49–51, 110]. A number of studies
suggest that the discrepancies in findings between studies
relate to differences in methodologies associated with the
measurement of blood pressure; it appears that the IUGR
offspring has an exaggerated stress response, so when the
measurement of blood pressure leads to stress in the rats,
they have an elevation in blood pressure [105, 111]. Indeed,
in many of the early studies, blood pressure was measured
only at one time point in unconditioned rats using tail-
cuff plethysmography; these papers are repeatedly cited in
the literature as evidence of IUGR leading to an elevation
in blood pressure, but it is now becoming well-accepted
that an elevated stress response was probably the mediator.
In fact, recent studies from the same laboratory show a
decrease in blood pressure when it is measured by telemetry,
but an elevation of blood pressure is apparent when blood
pressure is measured by tail-cuff plethysmography [105]. A
commonly quoted human study is that of Keller et al. [35]
where a significant reduction in the number of nephrons
per kidney was found in an autopsy study of middle-aged
white subjects from Germany who suffered from primary
hypertension when compared to normotensive subjects. It is
important to keep in mind when interpreting the findings
of such studies that hypertension can lead to renal injury
[112, 113] and so the reduction in nephron endowment
may have been a result of the hypertension, not the cause.
However, this does not appear to be the case in the study by
Keller et al. [35]; the proportion of sclerotic glomeruli in the
hypertensive kidneys was low (<5-6%).
Importantly, in our laboratory, we have conducted
a number of studies which have addressed the Brenner
hypothesis [49, 53, 114, 115]. In our IUGR models, the
data generated could neither refute nor support Brenner’s
hypothesis. Using gold standard stereological techniques,
we counted the number of nephrons as well as measured
renal filtration surface area within the IUGR kidney [49,
53]. In all instances of reduced nephron endowment, we
observed a compensatory increase in glomerular size with
a concomitant increase in glomerular filtration surface area
per glomerulus, such that renal filtration surface area was not
compromised [49, 53]. Hence, in our model of IUGR, since
renal filtration surface area was not compromised, it was
not surprising (based on Brenner’s hypothesis) that blood
pressure was not affected [49]. Using an alternative approach,
we have undertaken cross-breeding studies between spon-
taneously hypertensive rats and the normotensive Wistar
Kyoto strain [114]; in the F2 progeny (where there is a
random segregation of the SHR and WKY genes), the
offspring displayed a wide range of blood pressures. To
examine whether there was a direct corollary between the
level of blood pressure and nephron number and/or renal
filtration surface area, we conducted regression analyses in
the F2 progeny; in these studies, we found no significant
correlations between level of blood pressure and nephron
endowment or renal filtration surface area [114].
Hence, overall the experimental evidence now clearly
indicates that a reduced nephron endowment at the begin-
ning of life does not necessarily lead to hypertension.
However, it is conceivable that when the functional reserve
of nephrons is severely reduced, the glomeruli will eventually
reach the limits of physiological compensatory hypertrophy
and pathological mechanisms will come into play; elevations
in blood pressure may then also ensue. Indeed, prolonged
hyperfiltration of hypertrophied glomeruli can ultimately
lead to glomerulosclerosis and eventual glomerular loss [116,
117]. Since it is loss of glomeruli throughout life which accel-
erates risk and ultimately leads to end stage renal disease, it
is likely that vulnerability to disease will be increased when
the functional reserve is reduced prior to disease onset. In
this regard, it has been postulated that a congenital nephron
deficit acts as an initial insult to the kidney, which when
combined with subsequent postnatal insults (secondary
hits), leads to an exacerbated decline in renal function [118].
There are a number of experimental studies that support
this idea, whereas other studies do not. For example, IUGR
with a concomitant reduction in nephron endowment has
been shown to lead to more severe glomerulosclerosis in a
model of mesangioproliferative glomerulonephritis in rats
[119]. In addition, in our laboratory, we have shown that
the kidneys of IUGR rat offspring, with a reduced nephron
endowment, are more vulnerable to the infusion of advanced
glycation end products (AGEs) [50]. This implies that IUGR
kidneys with a congenital nephron deficit may be more
vulnerable to the induction of diabetes, given that AGE
formation is markedly elevated with hyperglycemia and their
accumulation in tissues is linked to the pathogenesis of end-
organ damage in diabetes [120]. Consistent with this idea,
the progression of renal disease is faster in patients with
a single kidney [121]. We have subsequently gone on to
examine the effect of induction of streptozotocin diabetes
in adulthood in our IUGR maternal protein restriction
rat model [122]. Interestingly, we found that the marked
impairment of hyperglycemia on renal function was not
exacerbated in the IUGR rats compared to controls [122].
This is possibly due to compensatory glomerular hypertro-
phy in the IUGR offspring. When Jones et al. [123] examined
the effect of induction of streptozotocin diabetes on renal
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structure in IUGR rats, they found that IUGR rats had a
greater proportional increase in renal size compared to non-
IUGR diabetic rats; following insulin treatmen,t the renal
hypertrophy was reduced but the glomeruli remained hyper-
trophied in the IUGR rats [123]. A number of experimental
studies have also examined the effect of feeding a high-salt
diet to IUGR rats as a secondary renal insult to rats with
a congenital nephron deficit; in general, it appears that the
IUGR kidneys can adequately cope with an increased salt
load [49, 51]. In this regard, findings from our laboratory
showed no evidence of salt-sensitive hypertension in IUGR
rats when fed a high-salt diet in adulthood; analysis of the
kidneys showed compensatory glomerular hypertrophy in
the IUGR rats with the congenital nephron deficit such that
renal filtration surface area was not different when compared
to controls. However, when nephron number is markedly
reduced this is not likely to be the case; administration of
a high-salt diet in uninephrectomised IUGR rats has been
shown to lead to a marked reduction in glomerular filtration
rate and elevation in blood pressure [124].
11. Summary
This paper has shown how IUGR and preterm birth can
adversely impact on the number of nephrons in the kidney
and lead to glomerular hypertrophy; this in turn can lead
to the induction of pathological processes within the kidney
when the glomeruli reach their limits of compensation. A
reduced nephron endowment does not necessarily lead to
hypertension but renders the kidney vulnerable to long-term
renal disease. Since IUGR is often a comorbidity of preterm
birth, it is likely that individuals who were born IUGR and
preterm will be particularly vulnerable to secondary renal
insults.
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